Skip to Main Content

Paper Details

Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumors.
Cold Spring Harb Mol Case Stud
4
2020
-NTRK fusions, -NTRK2 fusion, NTRK, NTRK fusions, NTRK2, RNA, SPECC1L, TRK, brain tumors, central nervous system cancers, chromoplexy, extracranial solid tumor, neurotrophic receptor tyrosine kinase, patient, pediatric, pediatric cancers, sarcoma, tumors, tyrosine
Author NameAffiliation
Chelsea MayohChildren's Cancer Institute, University of New South Wales
Louise E LudlowMurdoch Children's Research Institute, Royal Children's Hospital
Michelle HaberChildren's Cancer Institute, University of New South Wales
David S ZieglerChildren's Cancer Institute, University of New South Wales
David S ZieglerKids Cancer Centre, Sydney Children's Hospital
Glenn M MarshallChildren's Cancer Institute, University of New South Wales
Glenn M MarshallKids Cancer Centre, Sydney Children's Hospital
Mark J CowleyChildren's Cancer Institute, University of New South Wales
Mark J Cowley
Paul G EkertChildren's Cancer Institute, University of New South Wales
Paul G EkertMurdoch Children's Research Institute, Royal Children's Hospital
Paul G Ekert
Paul G EkertPeter MacCallum Cancer Centre
  • 1 - 13

Datasets

Release 1.2